Chemical industry
The latest news from across the chemistry-using industries, including pharmaceuticals, fine and speciality chemicals, agrochemicals and petrochemicals, from the Royal Society of Chemistry's magazine, Chemistry World
-
NewsEPA to revoke emissions limits on fossil fuel power plants
Trump administration estimates that its action will save over $300bn, but opponents criticise decision to ‘eliminate limits on climate pollution’
-
PodcastDrugging the ‘undruggable’ cancer proteins & conserving the Bayeux Tapestry
How did molecular glues help crack one of cancer’s toughest targets? And we explore the chemistry behind the investigation and conservation of the Bayeux Tapestry.
-
BusinessDeadly ammonia leak at fertiliser plant in Iraq
Two dead and 114 injured in incident at state-operated plant in Basra industrial area
-
Opinion‘Molecular glues’ are sticking it to cancer
Compounds that enhance selected protein–protein interactions to interfere with signalling or send proteins to be destroyed are making it possible to influence processes that were previously considered ‘undruggable’
-
BusinessProtein degrading breast cancer drugs navigate bumpy road to market
Camizestrant is now approved in US, UK and Europe despite uncertainty over long-term benefit, while vepdegestrant is approved in the US
-
OpinionDeadly reminders of the importance of risk assessment
Serious incidents in two university labs highlight the importance of knowing what to do when things go wrong
-
BusinessUS approves pancreatic cancer treatment that targets ‘undruggable’ proteins
Daraxonrasib success offers hope of further approvals for Ras-inhibitor drug candidates targeting various cancers
-
ResearchUpcycling sulfide-laden wastewater offers way to shelter chemical industries from sulfur supply crisis
Researchers suggest that method could generate a profit of up to $200 per tonne of sulfur recovered
-
BusinessAntibody data manipulation extends to thousands of images across 15 suppliers
Sleuths discover widespread, systematic alteration of Western blots and other antibody data
-
ResearchWaste chlorine upcycled into valuable materials using simple resin
Polystyrene-based resin could capture chlorine lost in industrial waste streams
-
BusinessProtein degrader approval offers hope to relapsed multiple myeloma patients
Highly potent molecular glue drug iberdomide doubles the number of patients reaching fewer than one myeloma cell per 100,000 in bone marrow
-
FeatureCracking the ubiquitin code to unlock new drug targets
The approval of the first Protac cancer drug marks a turning point in medicine – but scientists are only beginning to decode the complex molecular language that makes it possible
-
OpinionChemistry contains multitudes
There’s room (and need) for all the various subspecies of chemical scientists
-
ResearchOrganocatalyst streamlines oligonucleotide drug synthesis
New reaction controls phosphorus stereochemistry during the synthesis of phosphorothioate oligonucleotides
-
BusinessInvestigation flags chemical incompatibility in deadly US incident
Mixing nitric acid with sodium trithiocarbonate at Catalyst Refiners formed hydrogen sulfide
-
OpinionArtificial intelligence or clever artifice?
It’s important to be realistic about what AI can, and can’t, achieve, across the chemistry enterprise
-
News‘Organisations can’t solve a problem they can’t measure’: industry framework aims to improve chemical hazard monitoring
Colour-coded system could help companies benchmark progress as they transition to using ‘lower-risk’ chemicals
-
BusinessRecord low European river levels threaten chemical freight and process cooling
Cutting off bulk barges leaves few options for high-volume gaseous cargoes, where road and rail options are unsuitable
-
BusinessCombining AI with experiments to solve real-world materials problems
CuspAI’s Materials Foundry partner network includes 45 technology, data and materials chemistry companies to make and test its predictions
-
BusinessPfizer’s green chemistry team turns 25
What began as a grassroots initiative has become embedded across Pfizer’s research and manufacturing operations, helping reshape processes from Viagra to Paxlovid